Healthcare companies spearhead Swiss stocks advance

The Swiss Market Index climbed as Novartis advanced studies on multiple sclerosis while Roche releases arthritis drug.


Exide Tech seeks bankruptcy

Battery producer Exide Technology files for Chapter 11 bankruptcy after losing against competition. Global battery producer Exide Technologies filed for bankruptcy after it faced $31 million in interest payments in August and losing against rivals.

WestBridge Capital Enhances Team

UK-based private equity house WestBridge Capital appoints Pascal Wittlet as senior investment manager and relocates new offices in London to accommodate growing team.

Two companies join Green Power to create new Japan wind plants

Softbank's SB Energy and Mitsui & Co. partner with Green Power Investment Corp. to create a wind farm in Western Japan.


Latest News

Eighties software giant Manman's founder managed to raise $33 million for her new company, Kenandy.
As the London housing prices increases to a capital average of more than GBP500000, more households are rising to become renters.
Policy Exchange, an influential think tank, says that the British government should hand over a majority of its shares in Royal Bank of Scotland and Lloyds Banking Group to the public.
Elan rejects the newest bid from Royalty and seeks to look at other unsolicited interested parties.
AstraZeneca purchases Pearl Therapeutics for US$1.15 billion, making it the second firm in Britain to rebuild products through deal making.
JPMorgan Asset Management Inc. said that Africa is experiencing a strong growth over its sovereign wealth funds worldwide.
Amid the booming air travel industry, Nok Air and AirAsia X announced IPO for their shares to be used for the companies' expansion plans.
LongRiver Consortium will walk away from the proposed US$8.2 million bid unless Severn Trent engages in discussion with the company.
Kapil Siba, Indian Communications Minister, has called to meet different telecom companies to end lawsuits after a decrease in overseas investment transpired in the country.
Royalty Pharma urged the federal court in New York to lift the temporary restraining order it has ordered for the Royalty-Elan bid.